China Contract Research Organization Industry Report 2013-2016 in New Research Report at LifeScienceIndustryResearch.com

LifeScienceIndustryResearch.com adds Latest Report on “China Contract Research Organization (CRO) Industry Report, 2013-2016” to its store. Place a direct purchase order at http://www.lifescienceindustryresearch.com/purchase?rname=13614.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

Dallas, TX (PRWEB) May 27, 2014

China CRO industry has developed rapidly in recent years, registering a CAGR of 27.2% during 2007-2013, of which the market size reached RMB 36 billion in 2013, occupying 10% of global market share.

As China is full of talents, has advantage of relatively low costs and is rich in disease spectrum, the world’s renowned CRO companies, including Quintiles, Covance, Parexel and Charles River, have entered the Chinese market through sole proprietorship, corporation or acquisition, driving the industry towards standardization to some extent.

At present, there are about 500 companies involved in CRO market in China, but only a few of them are operating at scale and in good shape. WuXi AppTec, ShangPharma Corp, Asymchem and Hangzhou Tigermed Consulting Co., Ltd. are the leading local CRO companies in China, together holding around 15% of China CRO market.

Complete report is available at http://www.lifescienceindustryresearch.com/china-contract-research-organization-cro-industry-report-2013-2016.html .

WuXi AppTec is the largest local CRO player in China, making up about 10% of China CRO market; Hangzhou Tigermed Consulting Co., Ltd. is the only local CRO company listed in China, whose revenue has increased at a rate of above 30% annually over the last three years; Asymchem Inc. takes medical CMO as primary business, with its revenue arriving at RMB 542.8 million in 2013, and has embarked on IPO.

In order to share resources and improve overall competitiveness, some Chinese CRO companies are realizing mutual development by creating alliances, such as Alliance of Biotechnology Outsourcing (or ABO, including 38 companies such as Sino Biological Inc. and Pharmaron). In 2013, the revenue of ABO topped RMB 2 billion, up 11% from a year ago, of which RMB 1 billion came from international services.

China Contract Research Organization (CRO) Industry Report 2013-2016 highlights the following:

  •     Status quo, market size, competitive landscape, market characteristics and trend of China CRO industry;
  •     International environment, industry environment and policy environment of China CRO industry;
  •     Operation, development in China and outlook of 5 global and 9 Chinese CRO companies.

Purchase a copy of this report at http://www.lifescienceindustryresearch.com/purchase?rname=13614 .

Browse more reports on Pharmaceuticals Market at http://www.lifescienceindustryresearch.com/category/pharmaceuticals .

Contact sales(at)lifescienceindustryresearch(dot)com for further information.

About Us:
Life Science Industry Research is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, biotechnology, diagnostics, healthcare as well as medical devices and pharmaceuticals. We provide 24/7 online and offline support to our customers. Call +1 888 391 5441 with your research requirements or email the details on sales(at)lifescienceindustryresearch(dot)com Phone and we would be happy to help you find the business intelligence that you need.